Insulin Dose is Associated With Susceptibility to Overt Nephropathy in Type 1 Diabetes

被引：0
作者：
Orchard, Trevor J.
Costacou, Tina
Ellis, Demetrius
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
524-P
引用
收藏
页码：A134 / A135
页数：2
相关论文
共 50 条
  • [41] Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus
    Moczulski, DK
    Scott, L
    Antonellis, A
    Rogus, JJ
    Rich, SS
    Warram, JH
    Krolewski, AS
    [J]. DIABETIC MEDICINE, 2000, 17 (02) : 111 - 118
  • [42] INCREASED SUSCEPTIBILITY OF MALE TO OVERT NEPHROPATHY JAPANESE NIDDM
    NAKANO, H
    TUCHIDA, H
    NISHIMURA, M
    MIURA, Y
    SUZUKI, S
    WAKABAYASHI, Y
    YAMADA, K
    SHIBASAKI, T
    SAKAI, O
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 453 - 453
  • [43] Polymorphisms of the aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasian type 1 diabetes
    Fanelli, A
    Hadjadj, S
    Gallois, Y
    Fumeron, F
    Betoule, D
    Grandchamp, B
    Marre, M
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 (08) : A1 - A2
  • [44] Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes
    Grzeszczak, W
    Moczulski, DK
    Zychma, M
    Zukowska-Szczechowska, E
    Trautsolt, W
    Szydlowska, I
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (02) : 631 - 636
  • [45] Pohorphisms of the aldose reductase gene and susceptibility to retinopathy and nephropathy in caucasian type 1 diabetes
    Fanelli, A
    Hadjadj, S
    Gallois, Y
    Fumeron, F
    Betoule, D
    Grandchamp, B
    Marre, M
    [J]. ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2002, 95 (7-8): : 701 - 708
  • [46] A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy
    Dussol, B
    Iovanna, C
    Raccah, D
    Darmon, P
    Morange, S
    Vague, P
    Vialettes, B
    Oliver, C
    Loundoun, A
    Berland, Y
    [J]. JOURNAL OF RENAL NUTRITION, 2005, 15 (04) : 398 - 406
  • [47] Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy
    Gobor, Luiza Cristina
    Volanski, Waldemar
    Boritza, Katia Cristina
    de Souza, Susan Webber
    Anghebem Mauren Isfer Anghebem, Mauren Isfer
    Picheth, Geraldo
    de Moraes Rego, Fabiane Gomes
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 57
  • [48] Optimal insulin initiation dose in children with type 1 diabetes mellitus
    Al-Sallami, Hesham
    Lim, Isabelle
    Ben Wheeler
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 231 - 231
  • [49] The relationship between carbohydrate and the mealtime insulin dose in type 1 diabetes
    Bell, Kirstine J.
    King, Bruce R.
    Shafat, Amir
    Smart, Carmel E.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1323 - 1329
  • [50] Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy
    Breyer, JA
    Bain, RP
    Evans, JK
    Nahman, NS
    Lewis, EJ
    Cooper, M
    McGill, J
    Berl, T
    Rohde, R
    Hunsicker, LG
    Lachin, J
    Greenhouse, SW
    Verme, DA
    Turlington, TR
    Burrows, PK
    Wish, J
    Sheehan, J
    Pohl, M
    Berl, T
    Santiago, G
    Hunsicker, L
    Kern, EFO
    Lemann, J
    Blementhal, S
    Bresnahan, BS
    Hebert, L
    Goldfarb, S
    Kobrin, S
    Rodby, R
    Levey, A
    McLaughlin, M
    Williams, M
    McGill, J
    Whittler, F
    Rutecki, G
    Cattran, D
    Lietz, S
    Valaitis, D
    Hano, J
    Maxwell, D
    Porush, J
    Spitalewitz, S
    Shapiro, K
    Adler, S
    Tolchin, N
    Hoy, W
    Bernstein, R
    Svetkey, L
    Sharon, Z
    Rausenbaum, B
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (05) : 1651 - 1658
12345